Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage atm kinase'

Search results for: 'research area dna damage atm kinase'

Items 41-50 of 152

Page
per page
  1. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  2. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  3. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL
  4. CH5424802
    A8393 CH5424802
    Target: ALK
    Summary: ALK inhibitor,potent and ATP-competitive
  5. Reversine
    A3760 Reversine
    Target: Aurora Kinases
    Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  6. Nedaplatin
    B1986 Nedaplatin
    Summary: DNA synthesis inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥9.8 mg/mL
  7. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL
  8. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  9. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  10. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL

Items 41-50 of 152

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 150item
  2. Natural Products 1 item
Reversibility
  1. Reversible 8item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 11item
  2. Akt 1 item
  3. PI3K 7item
  4. Raf 5item
  5. Aurora Kinases 8item
  6. CSF-1R 2item
  7. mTOR 6item
  8. AP-1 1 item
  9. FLT3 6item
  10. GSK-3 4item
  11. PLK 3item
  12. Chk 3item
  13. Eph Receptors 2item
  14. VEGFR 11item
  15. PDGFR 8item
  16. c-Kit 3item
  17. RET 1 item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. Thymidylate Synthase 1 item
  20. p38 4item
  21. PKB 1 item
  22. Bcr-Abl 5item
  23. MEK 2item
  24. FGFR 2item
  25. Pim 3item
  26. MET 3item
  27. Src 4item
  28. Trk Receptors 1 item
  29. STAT 2item
  30. EGFR 6item
  31. ROCK 2item
  32. FAK 2item
  33. JAK 6item
  34. Syk 3item
  35. DNA-PK 4item
  36. AMPK 1 item
  37. Topoisomerases 2item
  38. ErbB 1 item
  39. DNA Methyltransferases 1 item
  40. ERK 1 item
  41. c-MET 4item
  42. PKC 3item
  43. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  44. Pyk2 2item
  45. LRRK2 3item
  46. Insulin and Insulin-like Receptors 2item
  47. ALK 1 item
  48. Sphingosine kinases (SphKs) 1 item
  49. Myosin light chain kinases (MLCKs) 1 item
  50. MK2 1 item
  51. Tie-2 1 item
  52. RSK 1 item
  53. ATM/ATR 3item
  54. Farnesyl Diphosphate Synthases 1 item
  55. CK2 3item
  56. HIPK2 1 item
  57. HIPK3 1 item
  58. P2X Receptors 1 item
  59. BLM 1 item
  60. Synthases/Synthetases 2item
  61. MAGL 1 item
  62. P110 1 item
  63. Hck 1 item
  64. RNA Polymerases 1 item
  65. Insulin Receptors 1 item
  66. IRG-1R 1 item
  67. Cdc2-like kinase (Clk) 1 item
  68. eEF-2 1 item
  69. Cdc7 1 item
  70. CMV 1 item
  71. ZAP-70 1 item
  72. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  73. Cytidine deaminases 1 item
  74. c-RET 1 item
  75. p70 rsk 1 item
  76. TAM kinase 1 item
  77. AXL 1 item
  78. c-Fms tyrosine kinase 1 item
  79. STK 1 item
  80. MSK 1 item
  81. Lyn kinase 1 item
  82. ITK 1 item
  83. NUAK 1 item
  84. DCLK2 1 item
  85. Lck 1 item
  86. PKD 1 item
  87. tropomyosin receptor kinase 1 item
  88. SK 1 item
  89. ATM 1 item
  90. Sirtuin 1 item
  91. PIKfyve 1 item
  92. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 10item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 2item
  5. Bladder Cancer 3item
  6. Bladder Carcinoma 2item
  7. Bladder Diseases 1 item
  8. B-lymphoid Malignancies 1 item
  9. Breast Cancer 26item
  10. Cancer 98item
  11. Cervical Cancer 4item
  12. Cholangiocarcinoma 1 item
  13. Chronic Lymphocytic Leukemia 1 item
  14. Clear Cell Renal Cell Carcinoma 1 item
  15. Colon Cancer 12item
  16. Colon Carcinoma 1 item
  17. Colorectal Cancer 16item
  18. Glioblastoma 10item
  19. Glioma 4item
  20. Hepatocellular Carcinoma 4item
  21. HIV Infections 2item
  22. Inflammatory Diseases 1 item
  23. Leukemia 6item
  24. Liver Cancer 2item
  25. Lung Cancer 6item
  26. Lung Carcinoma 1 item
  27. Lymphoma 9item
  28. Mantle Cell Lymphoma 1 item
  29. Melanoma 9item
  30. Multiple Myeloma 3item
  31. Myelofibrosis 1 item
  32. Myeloma 1 item
  33. Non-small Cell Lung Cancer 4item
  34. Ovarian Cancer 12item
  35. Pancreatic Cancer 14item
  36. Prostate Cancer 10item
  37. Psoriasis 1 item
  38. Renal Cancer 2item
  39. Renal Cell Carcinoma 2item
  40. Rheumatoid Arthritis 4item
  41. Sarcoma 1 item
  42. Squamous Cell Carcinoma 1 item
  43. Thyroid Cancer 3item
  44. Type 2 Diabetes 1 item